4.6 Article

Dihydropyridines Potentiate ATP-Induced Currents Mediated by the Full-Length Human P2X5 Receptor

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors

Stefan Bidula et al.

Summary: This study elucidates the structure-activity relationship of 5-BDBD at human P2X4 receptor and provides insights into the interaction between this antagonist and key residues. The findings are valuable for understanding the function of P2X4 receptor and developing related drugs.

MOLECULAR PHARMACOLOGY (2022)

Article Neurosciences

The discovery and development of gefapixant

Anthony P. Ford et al.

Summary: Gefapixant, also known as MK-7264, is the first clinically developed antagonist for the P2X3 subtype of ionotropic purinergic receptors. It has successfully completed Phase 3 investigations for the treatment of cough and is now under review for approval by the US FDA. Developed initially by Roche Pharmaceuticals, clinical development was continued by Afferent Pharmaceuticals before being acquired by Merck & Co., Inc.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2021)

Review Pharmacology & Pharmacy

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30

Peter Illes et al.

Summary: P2X receptors are cationic channels consisting of seven different subunits, with researchers having determined their structure and function. In addition, primitive ligand-gated counterparts related to P2X receptors have been cloned, and various selective antagonists have been discovered.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Highly accurate protein structure prediction with AlphaFold

John Jumper et al.

Summary: Proteins are essential for life, and accurate prediction of their structures is a crucial research problem. Current experimental methods are time-consuming, highlighting the need for accurate computational approaches to address the gap in structural coverage. Despite recent progress, existing methods fall short of atomic accuracy in protein structure prediction.

NATURE (2021)

Review Pharmacology & Pharmacy

Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders

Anindya Bhattacharya

FRONTIERS IN PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis

Hyunsoo Kim et al.

BMB REPORTS (2018)

Article Multidisciplinary Sciences

Localization of the gate and selectivity filter of the full-length P2X7 receptor

Anja Pippel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Pharmacology & Pharmacy

Interaction of Purinergic P2X4 and P2X7 Receptor Subunits

Markus Schneider et al.

FRONTIERS IN PHARMACOLOGY (2017)

Article Multidisciplinary Sciences

X-ray structures define human P2X3 receptor gating cycle and antagonist action

Steven E. Mansoor et al.

NATURE (2016)

Article Multidisciplinary Sciences

A Truncation Variant of the Cation Channel P2RX5 Is Upregulated during T Cell Activation

Pierre Abramowski et al.

PLOS ONE (2014)

Article Cell Biology

ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes

Siegfried Ussar et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Multidisciplinary Sciences

Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+

Mufeng Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Biochemistry & Molecular Biology

Purinergic signalling and cancer

Geoffrey Burnstock et al.

PURINERGIC SIGNALLING (2013)

Article Neurosciences

P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties

Vincent Compan et al.

JOURNAL OF NEUROSCIENCE (2012)

Article Biochemistry & Molecular Biology

The effect of anions on the human P2X7 receptor

Christoph Kubick et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)

Article Biochemistry & Molecular Biology

Effects of protons on macroscopic and single-channel currents mediated by the human P2X7 receptor

B. Flittiger et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)

Review Pharmacology & Pharmacy

Dihydropyridines: evaluation of their current and future pharmacological applications

Najmeh Edraki et al.

DRUG DISCOVERY TODAY (2009)

Article Biochemistry & Molecular Biology

Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1)

Eun Joo Roh et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Article Hematology

Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis

Ingrid M. Overes et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Article Biochemistry & Molecular Biology

P2X5 subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate

Wiebke Duckwitz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes

A Aschrafi et al.

JOURNAL OF MOLECULAR BIOLOGY (2004)

Article Pharmacology & Pharmacy

Pharmacological and biophysical properties of the human P2X5 receptor

XN Bo et al.

MOLECULAR PHARMACOLOGY (2003)

Article Pharmacology & Pharmacy

Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells

JL Harper et al.

BIOCHEMICAL PHARMACOLOGY (2003)

Article Neurosciences

Functional evidence of distinct ATP activation sites at the human P2X7 receptor

M Klapperstück et al.

JOURNAL OF PHYSIOLOGY-LONDON (2001)

Article Biochemistry & Molecular Biology

Genomic structure, developmental distribution and functional properties of the chicken P2X5 receptor

A Ruppelt et al.

JOURNAL OF NEUROCHEMISTRY (2001)

Article Pharmacology & Pharmacy

Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells

R Janssens et al.

BRITISH JOURNAL OF PHARMACOLOGY (2001)